FDA Adverse Event Malfunction Summary report: N

PENUMBRA COIL 400

MDR report key: 3090590 · Received May 2, 2013

Report

Report Number
3005168196-2013-00158
Event Type
Malfunction
Date Received
May 2, 2013
Date of Event
March 31, 2013
Report Date
April 2, 2013
Manufacturer
PENUMBRA, INC.
Product Code
HCG
PMA / PMN Number
K103305
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

RESULTS: THE COIL IS STRETCHED OUT OF ITS NORMAL SPECIFICATION. ADDITIONALLY, THE PROXIMAL CONSTRAINT BALL IS MISSING FROM THE COIL. A NOTE WAS RETURNED WITH THE PRODUCT THAT STATED "DETACHED INSIDE CATHETER (B)(6) 2013." CONCLUSION: THE COMPLAINT HAS BEEN EVALUATED AND CONFIRMED. THE COMPLAINT STATES THAT FRICTION WAS FELT WHEN ADVANCING THE COIL INTO THE CATHETER. DURING THE EVALUATION IT WAS NOTED THAT THE CONSTRAINT BALL WAS MISSING FROM THE COIL, INDICATING THAT EXCESSIVE FORCE WAS APPLIED TO THE COIL. THIS FORCE WAS GREATER THAN THE TENSILE STRENGTH SPECIFICATION OF THE MATERIAL, AND CAUSED THE CONSTRAINT BALL TO DETACH FROM THE SR-WIRE. SINCE THE COIL WAS THE ONLY PRODUCT RETURNED, THE CAUSE OF THIS FRICTION COULD NOT BE DIRECTLY DETERMINED. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.

Description of Event or Problem · 1

PATIENT WAS UNDERGOING COIL EMBOLIZATION TREATMENT FOR RIGHT ACA-ACOM ANEURYSM. THE ANEURYSM WAS ACCESSED WHERE FOUR COILS WERE PLACED TO ACHIEVE COMPLETE OBLITERATION OF THE ANEURYSM SACK. DURING THE PROCEDURE, THE FIRST COIL (COMPLEX SOFT 6X10) WAS LOADED INTO THE CATHETER AND THE FRICTION WAS NOTICED WHICH PREVENTED IT FROM BEING ADVANCED ALL THE WAY. WHILE RETRIEVING IT, THE COIL DETACHED PREMATURELY WITHIN THE MICROCATHETER. THE DEVICE MALFUNCTION IS NOT ASSOCIATED WITH ANY ADVERSE EVENTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
192292 PENUMBRA COIL 400 HCG, KRD HCG PENUMBRA, INC. F31096

Patients

Seq Age Sex Outcome Treatment
1 55 YR